Most cases of pancreatic ductal adenocarcinoma (PDAC) are asymptomatic in early stages, and the disease is typically diagnosed in advanced phases, resulting in very high mortality. Tools to identify individuals at high risk of developing PDAC would be useful to improve chances of early detection.
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction
Pasquali, Claudio;Basso, Daniela;Sperti, Cosimo;Padoan, Andrea;Milanetto, Anna Caterina;
2021
Abstract
Most cases of pancreatic ductal adenocarcinoma (PDAC) are asymptomatic in early stages, and the disease is typically diagnosed in advanced phases, resulting in very high mortality. Tools to identify individuals at high risk of developing PDAC would be useful to improve chances of early detection.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
GaleottiJMedGenet2021.pdf
accesso aperto
Tipologia:
Accepted (AAM - Author's Accepted Manuscript)
Licenza:
Altro
Dimensione
352.09 kB
Formato
Adobe PDF
|
352.09 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
